Sofosbuvir plus Ribavirin for the Treatment of Russian Patients with Chronic HCV Genotype 1 or 3 Infection

被引：0

作者：

Chulanov, Vladimir ^{[1
]}

Zhdanov, Konstantin ^{[2
]}

Kersey, Kathryn ^{[3
]}

Zhu, Yanni ^{[3
]}

Massetto, Benedetta ^{[3
]}

Zhuravel, Sergey ^{[4
]}

Romanova, Svetlana ^{[5
]}

Nurmukhametova, Elena ^{[6
]}

Morozov, Viacheslav ^{[7
]}

Kozhevnikova, Galina ^{[1
]}

Gogova, Larisa ^{[8
]}

Geyvandova, Natalia ^{[9
]}

Gankina, Natalia ^{[10
]}

Chesnokov, Evgenii ^{[11
]}

Burnevich, Eduard Z. ^{[12
]}

Bessonova, Elena ^{[13
]}

Abdurakhmanov, Djamal ^{[14
]}

Brainard, Diana M. ^{[3
]}

McHutchison, John G. ^{[3
]}

Bakulin, Igor G. ^{[15
]}

Isakov, Vasily ^{[16
]}

机构：

[1] Cent Res Inst Epidemiol, Moscow, Russia

[2] SM Kirov Mil Med Acad, St Petersburg, Russia

[3] Gilead Sci Inc, Foster City, CA 94404 USA

[4] Sci Res Inst Emergency Care, Moscow, Russia

[5] Ctr Prevent & Control AIDS & Infect Dis, St Petersburg, Russia

[6] Infect Clin Hosp 1, Moscow, Russia

[7] Med Co Hepatolog LLC, Samara, Russia

[8] Russian Acad Sci, Cent Clin Hosp, Moscow, Russia

[9] Stavropol Reg Clin Ctr Special Med Care, Stavropol, Russia

[10] Krasnoyarsk Reg Ctr Prevent & Control AIDS & Infe, Krasnoyarsk, Russia

[11] Consultat & Diagnost Ctr, Tyumen, Russia

[12] City Clin Hosp 24, Moscow, Russia

[13] Sverdlovsk Reg Clin Hosp 1, Ekaterinburg, Russia

[14] IM Sechenov First Moscow State Med Univ, Moscow, Russia

[15] Moscow Cent Sci Inst Gastroenterol, Moscow, Russia

[16] Russian Acad Med Sci, Inst Nutr, Moscow 109801, Russia

来源：

HEPATOLOGY | 2014年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

982

引用

页码：676A / 677A

页数：2

共 50 条

[1] Sofosbuvir plus Ribavirin in the Treatment of Egyptian Patients with Chronic Genotype 4 HCV Infection
Esmat, Gamal E.
Shiha, Gamal
Omar, Rabab F.
Hassany, Mohamad
Hammad, Radi
Khairy, Marwa
Samir, Waleed
Soliman, Reham
Brainard, Diana M.
Jiang, Deyuan
Kersey, Kathryn
Knox, Steven J.
Massetto, Benedetta
McHutchison, John G.
Doss, Wahid H.
HEPATOLOGY, 2014, 60 : 662A - 663A
[2] Sofosbuvir plus Ribavirin in the Treatment of Egyptian Patients with Chronic Genotype 4 HCV Infection
Doss, Wahid H.
Ruane, Peter J.
Shiha, Gamal
Ain, Dani
Soliman, Reham
Khairy, Marwa
Hassany, Mohamad
Riad, Joseph
Samir, Waleed
Omar, Rabab F.
Hammad, Radi
Meshrekey, Raymond
Gamil, Mostafa
Jiang, Deyuan
Massetto, Benedetta
Knox, Steven J.
Kersey, Kathryn
McHutchison, John G.
Esmat, Gamal E.
HEPATOLOGY, 2015, 62 : 737A - 738A
[3] Sofosbuvir plus Ribavirin in the Treatment of Chronic HCV Genotype 4 Infection in Patients of Egyptian Ancestry
Ruane, Peter J.
Ain, Dani
Riad, Joseph
Meshrekey, Raymond G.
Stryker, Richard
Wolfe, Peter R.
Basilyous, Lamese R.
Jiang, Deyuan
Knox, Steven J.
Kersey, Kathryn
Symonds, William T.
HEPATOLOGY, 2013, 58 : 736A - 736A
[4] Integrated Safety Analysis of Daclatasvir Plus Sofosbuvir, With or Without Ribavirin, in Patients With HCV Genotype 3 Infection
Bernstein, David
Landis, Charles S.
Lawitz, Eric
Luetkemeyer, Anne
Harris, Melissa
Bhore, Rafia
Swenson, Eugene S.
Ackerman, Peter
Rana, Khurram
Dieterich, Douglas
HEPATOLOGY, 2015, 62 : 571A - 571A
[5] Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Omata, Masao
Nishiguchi, Shuhei
Ueno, Yoshiyuki
Mochizuki, Hitoshi
Izumi, Namiki
Ikeda, Fusao
Toyoda, Hidenori
Yokosuka, Osamu
Nirei, Kazushige
Genda, Takuya
Umemura, Takeji
Takehara, Tetsuo
Sakamoto, Naoya
Nishigaki, Yoichi
Nakane, Kunio
Toda, Nobuo
Ide, Tatsuya
Yanase, Mikio
Hino, Keisuke
Gao, Bing
Garrison, Kimberly L.
Dvory-Sobol, Hadas
Ishizaki, Akinobu
Omote, Masa
Brainard, Diana
Knox, Steven
Symonds, William T.
McHutchison, John G.
Yatsuhashi, Hiroshi
Mizokami, Masashi
JOURNAL OF VIRAL HEPATITIS, 2014, 21 (11) : 762 - 768
[6] Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and-3 HCV infection: results from a Russian Phase IIIb study
Isakov, Vasily
Zhdanov, Konstantin
Kersey, Kathryn
Svarovskaia, Evguenia
Massetto, Benedetta
Zhu, Yanni
Knox, Steven J.
Bakulin, Igor
Chulanov, Vladimir
ANTIVIRAL THERAPY, 2016, 21 (08) : 671 - 678
[7] SOFOSBUVIR PLUS VELPATASVIR FOR CHRONIC HCV GENOTYPE 1, 2, 3, AND 4 INFECTION
Ahmed, H.
Attia, A.
Mohamed, A.
Elgebaly, A.
Negida, A.
JOURNAL OF HEPATOLOGY, 2016, 64 : S742 - S742
[8] Sofosbuvir plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 or 3 infection in India
Shah, S. R.
Chowdhury, A.
Mehta, R.
Kapoor, D.
Duseja, A.
Koshy, A.
Shukla, A.
Sood, A.
Madan, K.
Sud, R.
Nijhawan, S.
Pawan, R.
Prasad, M.
Kersey, K.
Jiang, D.
Svarovskaia, E.
Doehle, B.
Kanwar, B.
Subramanian, M.
Acharya, S. K.
Sarin, S.
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (05) : 371 - 379
[9] Safety of Ledipasvir/Sofosbuvir with and without Ribavirin for the Treatment of Patients with Chronic HCV Genotype 1 Infection: An Analysis of the Phase 3 ION trials
Alqahtani, Saleh
Afdhal, Nezam H.
Zeuzem, Stefan
Gordon, Stuart C.
Mangia, Alessandra
Kwo, Paul Y.
Yang, Jenny C.
Ding, Xiao
Pang, Phillip S.
McHutchison, John G.
Marcellin, Patrick
Kowdley, Kris V.
Sulkowski, Mark S.
HEPATOLOGY, 2014, 60 : 1140A - 1141A
[10] THE IMPROVEMENT OR REGRESSION OF FIBROSIS AFTER TREATMENT WITH SOFOSBUVIR PLUS RIBAVIRIN FOR HCV GENOTYPE 2 INFECTION
Jung, Young Kul
Kim, Taehyung
Yim, Hyung-Joon
Lee, Han Ah
Young, Yim Sun
Seo, Yeon Seok
Um, Soon Ho
Lee, Young-Sun
Kim, Ji Hoon
Yeon, Jong Eun
Byun, Kwan Soo
HEPATOLOGY, 2020, 72 : 575A - 576A

← 1 2 3 4 5 →